A Phase II Study Using Ibrutinib and Short-Course Fludarabine in Treatment-Naive CLL
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Fate Therapeutics
Center for International Blood and Marrow Transplant Research
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
Center for International Blood and Marrow Transplant Research
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)
Dana-Farber Cancer Institute
City of Hope Medical Center
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
City of Hope Medical Center